Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Marksans Pharma Limited
MARKSANS | NSE
286.85
INR-10.20
-3.43%
MARKSANS | NSE
About Marksans Pharma Limited
Sector
Healthcare
Industry
Drug Manufacturers-General
Earnings date
31/03/2024
As of date
10/10/2024
Close
286.85
Open
299.45
High
299.70
Low
285.10
Marksans Pharma Limited together with its subsidiaries engages in the research and development manufacturing marketing distribution and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics benign prostatic hyperplasia antidiabetic epilepsy anti-inflammatory hyperparathyroidism diabetes antacids neurology cardiovascular hormonal oncology gastroenterology antidiabetic pain management gynecology antibiotic antifungal antiulceratives vitamins dermatology cephalosporins injectables anti-allergy antibacterial and hypertension therapeutic areas. It also provides contract research and manufacturing services. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai India.
View LessMARKSANS | NSE
Risk
75.0
Sharpe
2.99
Luna's Score
61/100
Recommendation
Hold
Luna says (MARKSANS | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Strong Revenue Growth (> 10%)
Strong Sharpe Ratio (> 1.2)
What's not Working
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
55.2%1 month
75.0%3 months
63.9%6 months
60.5%Returns
Fundamental Ratios
PE
39.38
Fwd. PE
-
Price to book
6.34
Debt to equity
0.12
Debt to assets
0.09
Ent. to EBITDA
24.84
Ent. to rev.
5.82
PEG
-
Other Fundamentals
EBITDA
4.89B
MarketCap
129.99B
MarketCap(USD)
1.55B
Div. yield
0.21
Op. margin
18.29
Erngs. growth
28.90
Rev. growth
18.10
Ret. on equity
16.35
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
47.90
Range1M
69.39
Range3M
152.68
Volumes: Market Activity
Rel. volume
0.48
Price X volume
665.82M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 24.84 | 26.58 | Par |
| Ent. to Revenue | 5.82 | 6.75 | Par |
| PE Ratio | 39.38 | 43.49 | Par |
| Price to Book | 6.34 | 10.73 | Cheaper |
| Dividend Yield | 0.21 | 0.95 | Poor |
| Std. Deviation (3M) | 63.94 | 41.58 | Riskier |
| Debt to Equity | 0.12 | 0.14 | Par |
| Debt to Assets | 0.09 | 0.08 | Par |
| Market Cap | 129.99B | 191.03B | Emerging |
